July 3 (Reuters) - Cardiome Pharma Corp COM.TO
* Cardiome's partner steadymed submits u.s. New drug application for trevyent for the treatment of pulmonary arterial hypertension
* Cardiome pharma corp - cardiome expects to file trevyent for european medicines agency and health canada approval by end of 2017. Source text for Eikon: ID:nPnb3vLDTa Further company coverage: COM.TO